PatentDe  


Dokumentenidentifikation EP0612211 11.07.2002
EP-Veröffentlichungsnummer 0612211
Titel VERÄNDERUNG DER GESCHINDIGKEIT UND DER ART DES HAARWUCHSES
Anmelder The Gillette Co., Boston, Mass., US
Erfinder HANDELMAN, H., Joseph, New York, US;
AHLUWALIA, S., Gurpreet, Gaithersburg, US
Vertreter derzeit kein Vertreter bestellt
DE-Aktenzeichen 69232628
Vertragsstaaten AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, NL, SE
Sprache des Dokument EN
EP-Anmeldetag 04.11.1992
EP-Aktenzeichen 929242444
WO-Anmeldetag 04.11.1992
PCT-Aktenzeichen PCT/US92/09438
WO-Veröffentlichungsnummer 0009308687
WO-Veröffentlichungsdatum 13.05.1993
EP-Offenlegungsdatum 31.08.1994
EP date of grant 05.06.2002
Veröffentlichungstag im Patentblatt 11.07.2002
IPC-Hauptklasse A01N 37/10
IPC-Nebenklasse A01N 37/12   A61K 31/19   A61K 31/195   A61K 7/06   

Beschreibung[en]

This invention relates to a cosmetic method for altering the rate and character of mammalian hair growth particularly androgen-stimulated hair growth, by topical application to the skin of a composition containing an inhibitor of the enzyme L-asparagine synthetase.

It has previously been proposed that the rate of hair growth, as well as the character of hair can be modified by topical application of inhibitors of certain enzymes such as inhibitors of 5-α-reductase or ornithine decarboxylase, or such antiandrogens as androgen receptor binding agents, as described in U.S. Patent Nos. 4,720,489 and 4,885,289. Moreover, it has been theorized that certain other enzymes, including gamma glutamyl transpeptidase, are involved in various stages of hair follicle formation or of hair growth, but the relation between the various enzymes and the reactions which they control, as well as their effect upon each other and upon hair growth, has not been fully understood, as appears from Richards et al., Cancer Research, Vol. 42, 4143-4152 (1982) and DeYoung et al, Cancer Research, Vol. 38, 3697-3701 (1978); and Chase, Physiol. Zool. Vol 24, 1-8 (1951).

David A. Conney et al., Int. J. Biochem., Vol. 11, 519-539 (1980) discloses a range of organic compounds capable of inhibiting L-asparaginase synthetase. WO 86/02269 discloses topical compositions for altering hair growth comprising progesterone which inhibits L-asparagine synthetase (see David A. Conney et al. above, Table 11). US-A-4,283,386 discloses topical compositions for treating skin disorders and for cosmetic purposes (hair care) comprising cysteine sulfinic acids. US-A-4,439,432 discloses topical compositions comprising progesterone, which may be used for treating abnormal hair growth. US-A-4,248,861 discloses topical compositions for preventing deleterious effects of solar radiation comprising calcium pantothenate, which is a strong inhibitor of L-asparagine synthetase. (see David A. Conney et al. above, Table 9).

In the present invention it has been found that the rate and character of mammalian (including human) hair growth, particularly androgen-stimulated hair growth, can be modified by topical application to the skin of a composition containing an organic inhibitor of the enzyme L-asparagine synthetase. Inorganic inhibitors such as zinc chloride are undesirable because they tend to be irritants.

According to the present invention there is provided a cosmetic method of reducing the rate and altering the character of mammalian hair growth comprising applying to the mammalian skin, a composition comprising a non-toxic, dermatologically acceptable vehicle and a sufficient amount of an organic inhibitor of L-asparagine synthetase, but excluding progesterone.

Among the known organic inhibitors of the enzyme L-asparagine synthetase which can be used in the present invention are: guanidinosuccinic acid; oxaloacetic acid; L-cysteinesulfinic acid; diethyl aminomalonate; dipeptides containing L-aspartic acid (L-aspartylglycine, L-aspartyl-L-leucine, L-aspartyl-L-phenylalanine, L-aspartyl-L-proline, L-α-aspartyl-L-serine and L-α-aspartyl-L-valine); N-o-nitrophenylsulfenyl-L-aspartic acid; N-o-nitrophenylsulfenyl-L-glutamine; S-adenosyl-L-methionine; L-homoserine-β-adenylate; palmitic acid; lauric acid; and ethacrynic acid. Of these, guanidinosuccinic acid, ethacrynic acid, oxaloacetic acid, L-cysteinesulfinic acid and diethyl aminomalonate are preferred.

The composition contains, in addition to the inhibitor, a non-toxic dermatologically acceptable vehicle or carrier which is adapted to be spread upon the skin. The concentration of the inhibitor in the composition may be varied over a wide range, either in the form of a solution or dispersion, containing from 0.1 to 30% by weight of the inhibitor, preferably 2 to 15%, and the composition may be applied at a dosage rate of 10 to 25 mg/cm2 of skin. That is, the dosage of inhibitor itself is from 10 to 7,500 µg per square centimeter of skin. Penetration enhancers may also be present in the composition, including alcohol, acetone, propylene glycol, polyethylene glycol, dimethyl sulfoxide, 2-pyrrolidone, N-methyl-2-pyrrolidone, surfactants, azone, and the like, preferably in an amount effective to cause at least 10% inhibition of hair growth when the composition is applied to the skin adjacent the hair. The maximum amount of composition effectively applied is limited by the rate at which the inhibitor penetrates the skin.

The following specific examples are intended to illustrate more clearly the nature of the present invention without acting as a limitation upon its scope.

Example 1

A vehicle or carrier was prepared having the following composition: Component Percent concentration by weight Water 68% Ethanol 16% Propylene Glycol 5% Dipropylene Glycol 5% Benzyl Alcohol 4% Propylene Carbonate 2%

To separate portions of the vehicle were added amounts of four different inhibitors of L-asparagine synthetase as shown in Table 1 and the pH was adjusted with sodium hydroxide to achieve complete dissolution.

Four groups (eight animals in each group) of male intact Golden Syrian hamsters were provided. These animals were considered acceptable models for human beard hair growth in that they display oval shaped flank organs, one on each side, each about 8 mm. in major diameter, which grow thick black and coarse hair similar to human beard hair. These organs produce hair in response to androgens in the hamster. The flank organs of each hamster were depilated by applying a thioglycolate-based chemical depilatory (Surgex), and to one organ of each animal was applied 10µl of vehicle alone once a day, while to the other organ of each animal was applied an equal amount of vehicle containing inhibitor. After three weeks of such applications (five days a week), the flank organs were shaved and the amount of recovered hair (hair mass) from each was weighed. The extent of reduction in hair growth by the inhibitor was expressed as the percent decrease in hair mass on the organ treated with inhibitor as compared to the organ treated with vehicle alone. As a control, one group of eight animals had both flank organs of each animal treated with vehicle alone. The results were as shown in Table 1 below. <u>Inhibition of Hair Growth</u> <u>by Inhibitors of L-Asparagine Synthetase</u> Hamster Flank Organ Hair Mass (mg.) Treatment Group Amount pH Untreated Mean ± SD Treated Mean ± SD Percent Inhibition Control (vehicle) 7 1.92 ± 0.19 1.81 ± 0.24 Guanidinosuccinic acid 6% 7 1.48 ± 0.09 0.64 ± 0.07 57.1% Oxaloacetic acid 10% 3-4 1.44 ± 0.18 0.77 ± 0.11 38.0% Cysteinesulfinic acid 6% 3-4 1.44 ± 0.16 1.10 ± 0.19 25.5% Diethyl aminomalonate 10% 3-4 1.53 ± 0.18 1.18 ± 0.18 23.3%

Example 2

Compositions were prepared containing 5%, 10%, and 20% respectively of guanidinosuccinic acid in the vehicle described in Example 1 above and applied as in that Example. The results were as shown in Table 2. <u>Inhibition of Hair Growth</u> <u>by Guanidinosuccinic Acid</u> Hamster Flank Organ Hair Mass (mg.) Treatment Group Amount pH Untreated Mean ± SD Treated Mean ± SD Percent Inhibition Control 7 2.17 ± 0.24 1.78 ± 0.25 Guanidinosuccinic acid 5% 7 1.52 ± 0.19 0.69 ± 0.14 52.6 ± 8.2 Guanidinosuccinic acid 10% 7 1.86 ± 0.18 0.72 ± 0.19 55.7 ± 15.1 Guanidinosuccinic acid 20% 7 1.83 ± 0.31 0.38 ± 0.12 80.1 ± 5.8

It was found that similar topical treatments with a 10 and 20% solution of guanidinosuccinic acid (two treatments over a 24 hour period using groups of 10 animals) resulted in a respective 76 and 85% reduction of L-asparagine synthetase activity in the hamster hair follicles.

Example 3

Compositions were prepared containing 10% and 20% by weight of ethacrynic acid respectively in the vehicle described in Example 1 above, and applied to hamster flank organs under the same conditions as described in Example 1 except that seven animals were in each group instead of eight. The results are shown in Table 3 below. <u>Inhibition of Hair Growth</u> <u>by Ethacrynic Acid</u> Hamster Flank Organ Hair Mass (mg.) Treatment Group Amount pH Untreated Mean ± SD Treated Mean ± SD Percent Inhibition Control 7 2.85 ± 0.26 2.82 ± 0.32 Ethacrynic acid 10% 5 3.09 ± 0.27 1.82 ± 0.22 42% Ethacrynic acid 20% 5 2.47 ± 0.27 0.91 ± 0.10 63%

Similar results can be obtained using other organic inhibitors of L-asparagine synthetase.


Anspruch[de]
  1. Kosmetisches Verfahren zur Verringerung der Geschwindigkeit und Veränderung des Charakters des Haarwuchses von Säugern, umfassend das Aufbringen einer Zusammensetzung auf die Haut, welche Zusammensetzung einen nichttoxischen, dermatologisch duldbaren Träger aufweist und eine ausreichende Menge eines organischen Hemmstoffes von L-Asparagin-Synthetase, ausgenommen jedoch Progesteron.
  2. Verfahren nach Anspruch 1, wobei die Menge des organischen Hemmstoffes 0,1% bis 30 Gewichtsprozent bezogen auf das Gewicht der Zusammensetzung beträgt und wobei der Hemmstoff ausgewählt wird aus Guanidinsuccinsäure, Oxalessigsäure, Cysteinsulfinsäure, Diethylaminomalonat oder Ethacrinsäure.
  3. Verfahren nach Anspruch 1 oder 2, wobei die Zusammensetzung für die Aufbringung von 10 bis 7,500 µg Hemmstoff pro Quadratzentiemter Haut bemessen ist.
Anspruch[en]
  1. A cosmetic method of reducing the rate and altering the character of mammalian hair growth comprising applying to the mammalian skin, a composition comprising a non-toxic, dermatologically acceptable vehicle and a sufficient amount of an organic inhibitor of L-asparagine synthetase, but excluding progesterone.
  2. The method of claim 1, wherein said amount of said organic inhibitor is 0.1 to 30%, based on the total weight of the composition and wherein said inhibitor is selected from guanidinosuccinic acid, oxalacetic acid, cysteine sulfinic acid, diethyl aminomalonate or ethacrynic acid.
  3. The method of claims 1 or 2, wherein said composition is adapted for application from 10 to 7,500 µg of inhibitor per square centimeter of skin.
Anspruch[fr]
  1. Méthode cosmétique de réduction de la vitesse et d'altération du caractère de la pousse des poils de mammifères comprenant l'application, sur la peau du mammifère, d'une composition comprenant un véhicule dermatologiquement acceptable, non-toxique, et une quantité suffisante d'un inhibiteur organique de la L-asparagine synthétase, exception faite de la progestérone.
  2. Méthode selon la revendication 1, dans laquelle ladite quantité dudit inhibiteur organique est de 0,1 à 30 % par rapport à la masse totale de la composition et dans laquelle ledit inhibiteur est choisi parmi l'acide guanidinosuccinique, l'acide oxaloacétique, l'acide cystéinesulfinique, l'aminomalonate de diéthyle ou l'acide éthacrynique.
  3. Méthode selon les revendications 1 ou 2, dans laquelle ladite composition est appropriée à l'application de 10 à 7 500 µg d'inhibiteur par centimètre carré de peau.






IPC
A Täglicher Lebensbedarf
B Arbeitsverfahren; Transportieren
C Chemie; Hüttenwesen
D Textilien; Papier
E Bauwesen; Erdbohren; Bergbau
F Maschinenbau; Beleuchtung; Heizung; Waffen; Sprengen
G Physik
H Elektrotechnik

Anmelder
Datum

Patentrecherche

Patent Zeichnungen (PDF)

Copyright © 2008 Patent-De Alle Rechte vorbehalten. eMail: info@patent-de.com